Scientists zoom in to watch DNA code being read

January 17, 2018, Institute of Cancer Research
Architecture of TFIIIB subunits and upstream DNA assembly. a, Positions of TFIIIB transcription factor and Pol III interacting subunits. Brf1, TBP, Bdp1, C37 and C34 are depicted as ribbon models; Pol III protrusion and wall domains are depicted as molecular surfaces. b, Detailed view of the Bdp1–C37 platform. Bdp1, C37 and C34 subunits are depicted as ribbon models in the cryo-EM map. Credit: Nature (2018). oi:10.1038/nature25441

Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by .

Researchers used an advanced form of electron microscopy called Cryo-EM, for which the Nobel Prize in Chemistry was awarded in 2017, to zoom in and capture images of the reading mechanism in unprecedented detail.

The discovery of exactly how the molecular mechanism works—published in the journal Nature—could open up new approaches to cancer treatment.

Scientists at The Institute of Cancer Research, London, captured images of called RNA Polymerase III in the act of transcribing a gene in exquisite and unprecedented detail.

The work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), Cancer Research UK and the Wellcome Trust.

RNA polymerase III is crucial to life for all eukaryotic —including all animals and plants. In cancer, it is more active, causing cells to produce larger numbers of the building blocks they need to grow and multiply.

Cryo-EM is so powerful that it can take pictures of tiny molecules—approximately 5 nanometers or 20000th of the width of a human hair—at almost an atomic level.

It allowed researchers to see for the first time how components of the RNA polymerase III complex and accessory molecules interact and communicate with each other, suggesting how drugs might be employed to split the complex up.

The new study captured the molecular machinery in the act of binding to DNA, separating the two strands and getting ready to transcribe the DNA code.

Cryo-EM involves freezing and imaging samples at -180°C to preserve minute details of protein shapes. This type of microscopy is also an emerging and exciting approach in cancer drug design.

Scientists at The Institute of Cancer Research (ICR) used the technique to reveal five key stages in which the complex reshapes itself to successfully transcribe the DNA code. Each of these stages could potentially become the target of new cancer drugs.

The researchers looked at the molecular mechanism in yeast cells, but the same machinery is used in humans.

The complex reads the DNA code and makes material known as transfer RNA—an essential part of producing the protein building blocks needed to allow cells to grow or to make new cells.

Cancer cells need large numbers of these protein building blocks as they rapidly grow and divide, so they can become particularly reliant on components of the RNA polymerase III complex.

Dr. Alessandro Vannini, Team Leader in Structural Biology at The Institute of Cancer Research, London, said:

"We used a really exciting new type of microscopy called Cryo-EM to do something no scientists have been able to do before. We were able to freeze and catch the RNA polymerase III complex in the act of attaching to, separating and reading the DNA code. We obtained almost a million of independent snapshots and, using powerful computers we grouped similar snapshots together, enhancing their detail to obtain a vivid reconstruction of this machinery at work."

"Now we know how the components of this crucial fit together, we may be able to design drugs that turn the system on or off—and these could offer a whole new way of treating cancer."

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"Cryo-EM is revolutionising molecular and cellular biology, allowing us to look in minute detail at molecular machines within cells and how they work. The technique is helping scientists to discover weaknesses in that could be targeted by the next generation of drugs.

"This beautiful study has unveiled a fundamental cog in the inner workings of cells, and one that is often exploited by cancers. It's a hugely important finding in cell biology, and I hope that in future it will lead to new treatments for cancer patients."

Dr. Amanda Collis, interim Executive Director of Science at BBSRC, said:

"Cryo-EM is rapidly advancing our knowledge of the structure and behaviour of biological molecules, and this exciting discovery demonstrates how fundamental understanding of biological systems can open the door to the development of potential new cancer therapies."

Universities and Science Minister Sam Gyimah said:

"This incredible new advancement in DNA decoding will further our understanding of disease, potentially leading to vital lifesaving treatment, including new ways to tackle cancer.

"The recently published Life Sciences Sector Deal, through our Industrial Strategy, will pave the way for more investment in innovative new treatments and technologies that will not only improve patient lives, but also drive economic growth making Britain fit for the future."

Explore further: Targeting breast cancer through precision medicine

More information: Structural basis of RNA Polymerase III transcription initiation, Nature (2018). nature.com/articles/doi:10.1038/nature25441

Related Stories

Targeting breast cancer through precision medicine

January 9, 2018
University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer.

Scientists map one of most important proteins in life—and cancer

July 20, 2014
Scientists reveal the structure of one of the most important and complicated proteins in cell division – a fundamental process in life and the development of cancer – in research published in Nature today.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.